The National Cancer Institute (NCI) awarded a $194,778 Project Grant (CFDA 93.395 - Cancer Treatment Research) to Weill Medical College of Cornell University to optimize strategies for improving NCI-sponsored clinical trial participation across the Weill Cornell Medicine - Meyer Cancer Center sphere, which serves a diverse population of approximately 6 million patients in the New York City metropolitan area.
The grant will support efforts by the principal investigator, Dr. Tagawa, to expand the Meyer Cancer Center's clinical trials portfolio, with a focus on increasing participation in NCI-sponsored trials, especially among minority and underserved populations, across the center's locations in Manhattan, Brooklyn, and Queens. Dr. Tagawa has extensive experience leading and mentoring multi-disciplinary teams on NCI clinical trials through his roles with the Alliance for Clinical Trials in Oncology. The project aims to leverage the infrastructure and expertise he has built to grow the clinical research portfolio across disease management teams at the Meyer Cancer Center.